U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342114) titled 'A Dose-Escalation Study of RO7875913 in Healthy Participants' on Jan. 06.
Brief Summary: The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of RO7875913 in healthy participants.
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: RO7875913
Participants will receive RO7875913 as per the schedule described in the protocol.
DRUG: Placebo
Participants will receive placebo as per the schedule described in the protocol.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Genentech, Inc.
Published by HT Digital Content Services with permiss...